One-year medication cost of Belzutifan and self-pay reference after medical insurance reimbursement

Belzutifan (Belzutifan) is an oral targeted drug mainly used to treat renal cell carcinoma and other tumors related to VHL syndrome. In China, bestivan is already on the market, but it has not yet been included in the medical insurance system, which means that patients need to purchase it at their own expense, which is relatively expensive. The drug specification is 40mg*90 tablets. According to the dose calculation of 120mg once a day, you need to take 3 tablets once a day.

According to this dosage, the required dosage per year is approximately 3tablets/days × 365days = 1,095tablets, which means approximately 12boxes are needed (each box90pills). Due to the high price of domestic original drugs, the cost per box may be in the range of tens of thousands of RMB. Therefore, the total out-of-pocket expenses per year may reach hundreds of thousands of RMB. The specific cost needs to be determined based on the actual selling price in the hospital pharmacy.

For patients who want to reduce treatment costs, Lao version of generic drugs from legal foreign channels is a viable option. The price per box is about more than 5,000 yuan, and the drug ingredients are basically the same as the original drugs. Purchasing generic drugs through formal channels can not only reduce financial pressure, but also ensure drug quality and efficacy. However, it is still necessary to strictly follow the doctor's recommendations and avoid self-dispensing or changing drug sources.

Overall, the one-year medication cost of Bestifan is relatively high and is not covered by medical insurance. Patients need to plan their financial budget in advance and communicate with their doctors about treatment plans. If economic conditions are limited, overseas regular generic drugs provide an economically feasible alternative, but drug safety and efficacy still require the guidance of doctors and standardized management to ensure the continuity and effectiveness of treatment.

Reference materials:https://www.drugs.com/